22 September 2022
Latham & Watkins Advises Octagon Therapeutics’ Research Alliance With Novo Nordisk
Advising firms
Deal team
1 lawyer named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Jekkie Kim Lead | Latham & Watkins LLP | Partner | healthcare and life sciences | Bay Area |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Octagon TherapeuticsJoint venture party
- Counterparties
- Novo Nordisk (Joint venture party)